CortiCare Blog | CortiCare

Psychogenic Non-Epileptic Seizures: Common and Difficult to Diagnose

Psychogenic non-epileptic seizures are common and have a wide variety of symptoms, but can often be misdiagnosed and misunderstood.

CortiCare awarded Ambulatory Care Accreditation from The Joint Commission

CortiCare is recognized for its commitment to quality patient care and has earned The Joint Commission’s Gold Seal of Approval®

EEG in Therapeutic Hypothermia Following Global Ischemic Injury to the Brain

TH in the setting of global ischemic injury to the brain is a treatment that benefits from EEG monitoring in adult, pediatric, and neonatal patients.

The Utility of EEG in Clinical Trials

EEG plays an important role in inclusion/exclusion criteria for safety and efficacy evaluations and as biomarkers in clinical trials. Given the heterogeneity of understanding of the strengths and the limitations of EEG in this context, we provide a brief commentary to inform drug sponsors, contract research organizations, and academic partners on some of the questions to consider.

CortiCare prepares for the challenges of 2021

Find out how CortiCare is evolving to meet the anticipated demand and market growth going forward into 2021 and beyond. A recent article in Healthcare Tech Outlook by Jeff Kuznia, Director of Marketing at CortiCare, summarizes the company’s multipronged approach to addressing the EEG service needs of its customers and the goal of improving patient […]

CortiCare named a Top 10 Company in Ambulatory Care

December 28, 2020 CortiCare was recently named one of the top 10 companies in the forefront of ambulatory care by Healthcare Tech Outlook magazine – addressing the need for in-home ambulatory EEG. For more than 12 years CortiCare has been delivering top-quality ambulatory EEG studies and in the last two years alone has grown to […]

EEG – a Frontline Tool for the ED

The role for EEG evaluation and monitoring in the ED is well documented, though … there are challenges to obtaining an EEG recording and having it accurately read in a timely manner.

Update on the impact of COVID-19 on EEG activity

Reports from Wuhan and Lombardy early in this pandemic indicated that COVID-19 has a significant impact on the brain. In the acute period of SARS-CoV-2 infection, 34.6 % patients were observed to have neurological symptoms including stroke, headache, and seizures. Basic science studies on mechanism of viral entry and vascular involvement have corroborated these observations […]

Long-Term Video-EEG Studies: EMU vs. In-Home

Long-term EEG studies can take days or weeks to schedule and complete, and studies taking place in the Epilepsy Monitoring Unit (EMU) come with increased risk in today’s circumstances. The COVID-19 pandemic has tightened restrictions in hospitals everywhere. For many patients, (in particular, those who only require scalp EEGs and are not having their antiepileptic […]

Teleneurology is Helping Rural Hospitals Retain Patients

Telemedicine or telehealth has been described as a path to virtual integrated care and is changing health care delivery in communities across the United States (US). The use of telehealth in hospitals has grown rapidly from 35% in 2010 to 76% in 2017, connecting patients to vital health care services with consulting practitioners at a […]